Skip to main content

Table 2 Clinical and pathological characteristics of established xenograft models

From: Establishment of patient-derived xenograft models and cell lines for malignancies of the upper gastrointestinal tract

ID Gender Age Location Stage (TNM) Diagnosis Diff. patient Diff. xeno Xeno take* Cell lines Treatment +
PC028 F 74 liver metastasis pTxNxM1 PDAC moderate moderate 4 yes none
PC053M M 78 liver metastasis pTxN1M1 PDAC moderate poor 12 yes none
PC053B M 78 biopsy tumor pTxN1M1 PDAC na poor 12 yes none
PC067 F 73 resected tumor pT3N1M0 PDAC poor moderate 26 yes none
PC072 M 65 resected tumor pT3N1M0 PDAC moderate moderate 24 no growth none
PC076 M 64 resected tumor pT3N1M0 PDAC poor-moderate moderate 33 yes none
PC084 M 83 liver metastasis pTxN1M1 PDAC moderate-well moderate 11 yes none
PC086 M 66 resected tumor pT4N1M0 PDAC moderate moderate 18 na none
PC090 F 78 resected tumor pT4N1M0 PDAC moderate well 19 yes none
PC093 M 61 resected tumor pT4N1M0 PDAC moderate moderate 37 ongoing none
PC096 F 62 liver metastasis pTxNxM1 PDAC moderate moderate 29 ongoing none
PC099 F 46 liver metastasis cT3NxM1 PDAC well moderate 23 ongoing none
EAC007B F 50 biopsy tumor pT3N1M0 EAC moderate moderate-well 10 yes none
EAC007R F 51 resected tumor pT3N1M0 EAC moderate poor-moderate 19 yes chemoradiation
ESC008 F 37 resected tumor pT4N0M0 ESC moderate poor-moderate 3 na chemoradiation
EAC018 M 73 resected tumor pT3N1M0 EAC moderate moderate-well 16 yes chemoradiation
EAC023 M 58 biopsy tumor pT3N2M0 EAC poor poor 14 yes none
EAC026 M 69 lymph node metastasis pT2N2M0 EAC poor poor 16 yes chemoradiation
EAC027 M 66 adrenal gland metastasis pT3NxM1 EAC poor poor 14 yes radiation
EAC031B M 78 biopsy tumor pT3N3Mx EAC moderate poor 14 yes none
EAC031M M 78 liver metastasis pT3N3Mx EAC moderate moderate 17 yes chemotherapy
EAC033 M 54 liver metastasis pT4N2M1 EAC poor poor 16 yes chemotherapy
EAC037 M 68 thoracle TH metastasis na EAC poor poor 11 yes chemotherapy
EAC038 M 76 lung metastasis pT3N1M0 EAC poor poor 28 na chemoradiation
ESC040 F 67 pelvis metastasis pTxN2Mx ESC moderate poor-moderate 17 ongoing chemoradiation
EAC041 M 73 biopsy tumor pTxN1M0 EAC moderate moderate 3 ongoing none
ESC043 M 58 biopsy tumor pT3N1Mx ESC na moderate-well 10 na none
ESC049 F 66 biopsy tumor pT3N1M0 ESC moderate moderate 12 na none
EAC050 M 69 biopsy tumor pT3N2Mx EAC na poor-moderate 11 na none
  1. *time in weeks required for the primary patient material to grow out and be retransplanted.
  2. +neo-adjuvant treatment before resection.
  3. Abbrevations: M male, F female, Diff. Differentiation grade, na not assessed due to limited or inconclusive material, PDAC pancreatic ductal adenocarcinoma, EAC esophageal adenocarcinoma, ESC esophageal squamous cell carcinoma.
Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us